Esta donación ayudará a desarrollar la investigación del laboratorio del Dr. Andrés sobre el síndrome de progeria de Hutchinson-Gilford (del inglés HGPS), una enfermedad genética ultra-rara, co...
Read moreResearchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a study demonstrating the efficacy of CAR-T GYA01 thera...
Read moreIt has been analyzed recent advances in the diagnosis and treatment of primary autoimmune neuropathies—a group of rare and debilitating disorders of the peripheral nervous system that includes Guill...
Read moreThe findings suggest that inhibiting CNNM4, combined with GalNAc siRNA technology, could offer a targeted, safe, and effective treatment, opening new avenues for personalized therapies against this ag...
Read moreVeritas Genetics, a world leader in medical genomics, has acquired qGenomics, a leading company in carrier screening and array analysis. The scientific and technological expertise of qGenomics will al...
Read moreProceeds to support further clinical development of lead program ATX-01 in Myotonic Dystrophy Type1, a unique therapy currently in Phase I-IIa, targeting miR23b
Read moreOryzon Genomics is proud to announce its participation as a sponsor of the first-ever Phelan-McDermid syndrome (PMS) burden of illness study. The study is led by CureShank, a research advocacy organiz...
Read moreA study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilise nearly all mutate...
Read moreCuando las células de sarcoma de Ewing son infectadas por el adenovirus terapéutico, estas expresan el gen ‘suicida’ HSV-TK. Este gen es inocuo, pero cuando se combina con la prodroga ganciclovi...
Read moreIt has been designed and experimentally validated new synthetic proteins that can edit the human genome more efficiently than proteins provided by nature that will be of great use in improving the cur...
Read moreLa Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) ha anunciado la ampliación de su procedimiento de evaluación acelerada para ensayos clínicos en fases tempranas, una medida que c...
Read moreOtros objetivos del hackaton han sido demostrar la utilidad de nuevas técnicas para diagnosticar a pacientes complejos, establecer nuevos circuitos y redes de colaboración, así como sensibilizar so...
Read more